Trials / Unknown
UnknownNCT05955118
Hydrus Microstent as a Quality of Life Consideration
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 38 (estimated)
- Sponsor
- InSight Vision Center Medical Group, Inc · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study aims to identify if Hydrus microstent implantation in patients with open angle glaucoma (OAG) at the time of cataract surgery improves quality of life for patients and explore what quality of life factors motivate patients.
Detailed description
Prospective, interventional single arm study of patient-reported outcomes (PRO) via GSS with pre and post ocular surface disease assessment in subjects undergoing bilateral phaco and Hydrus implantation; Study will also explore other QOL factors that may motivate patients to accept Hydrus via Glauc-QOL36 and customized questions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hydrus Microstent | Hydrus Microstent placed at the time of cataract surgery |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2024-04-01
- Completion
- 2024-04-01
- First posted
- 2023-07-21
- Last updated
- 2023-07-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05955118. Inclusion in this directory is not an endorsement.